ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 88,500
+3,800 (4.49%)
Jul 31, 2026, 3:30 PM KST
ST Pharm Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, ST Pharm stock has a consensus rating of "Strong Buy" and an average price target of ₩186,000. The average 1-year stock price forecast is 110.17% higher than the current stock price, while the lowest is ₩140,000 (+58.19%) and the highest is ₩210,000 (+137.29%).
Price Target: ₩186,000 (+110.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ST Pharm stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 7 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 11 | 10 | 10 |
Financial Forecast
Revenue This Year
418.80B
from 331.68B
Increased by 26.27%
Revenue Next Year
504.81B
from 418.80B
Increased by 20.54%
EPS This Year
3.41K
from 2.69K
Increased by 27.01%
EPS Next Year
4.36K
from 3.41K
Increased by 27.83%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.